Saurabh Saha
CIK 1861926 · Chief Executive Officer · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CNTA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM
CHESHIRE, X0 WA14 2DT
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLVT | Director | 170,601 | $2.06 | $352.3K | $135.0K | 6 | 2026-05-15 |
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Executive Officer | 259,017 | $40.50 | $10.49M | -$14.76M | 34 | 2025-07-21 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| CNTA | Direct | 221,017 | 85.3% | 2025-07-21 |
| By trust | 38,000 | 14.7% | 2025-07-21 | |
| Total | 259,017 |
Recent Filings · Page 7 of 7
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Grant (A) | +211,400 | $0 | EDGAR |
| 2023-01-04 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −44,025 | -$136.5K | EDGAR |
| 2022-07-06 | Centessa Pharmaceuticals plc (CNTA) Delisted | Grant (A) | +750,000 | $0 | EDGAR |
| 2022-06-27 | Centessa Pharmaceuticals plc (CNTA) Delisted | Buy (P) | +10,000 | $46.3K | EDGAR |
| 2022-02-04 | Centessa Pharmaceuticals plc (CNTA) Delisted | Buy (P) | +5,000 | $48.7K | EDGAR |
| 2022-02-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-18 | Centessa Pharmaceuticals plc (CNTA) Delisted | Buy (P) | +23,000 | $282.5K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
34 sales · $70.55M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-01-16 | Centessa Pharmaceuticals | 358,792 | $8.06M | $22.45 | 2026-01-21 |
| 2026-01-15 | Centessa Pharmaceuticals | 1,100,000 | $24.67M | $22.42 | 2026-01-21 |
| 2026-01-14 | Centessa Pharmaceuticals | 126,905 | $2.79M | $22.02 | 2026-01-21 |
| 2026-01-13 | Centessa Pharmaceuticals | 86,493 | $1.92M | $22.16 | 2026-01-21 |
| 2026-01-12 | Centessa Pharmaceuticals | 45,676 | $1.00M | $21.95 | 2026-01-21 |
| 2026-01-09 | Centessa Pharmaceuticals | 121,618 | $2.74M | $22.53 | 2026-01-21 |
| 2026-01-08 | Centessa Pharmaceuticals | 118,416 | $2.62M | $22.14 | 2026-01-21 |
| 2026-01-07 | Centessa Pharmaceuticals | 147,455 | $3.35M | $22.72 | 2026-01-21 |
| 2026-01-06 | Centessa Pharmaceuticals | 122,390 | $2.80M | $22.89 | 2026-01-21 |
| 2026-01-05 | Centessa Pharmaceuticals | 147,920 | $3.36M | $22.71 | 2026-01-21 |
| 2026-01-02 | Centessa Pharmaceuticals | 124,335 | $2.98M | $23.94 | 2026-01-21 |
| 2025-06-20 | Centessa Pharmaceuticals plc | 55,000 | $694.8K | $12.63 | 2025-07-21 |
| 2025-05-20 | Centessa Pharmaceuticals plc | 55,000 | $699.1K | $12.71 | 2025-06-20 |
| 2025-04-22 | Centessa Pharmaceuticals plc | 40,344 | $501.5K | $12.43 | 2025-05-20 |
| 2025-04-21 | Centessa Pharmaceuticals plc | 14,656 | $180.1K | $12.29 | 2025-04-22 |
| 2025-03-20 | Centessa Pharmaceuticals plc | 55,000 | $918.1K | $16.69 | 2025-04-21 |
| 2025-02-20 | Centessa Pharmaceuticals plc | 55,000 | $876.1K | $15.93 | 2025-03-20 |
| 2025-01-21 | Centessa Pharmaceuticals plc | 55,000 | $867.4K | $15.77 | 2025-02-20 |
| 2024-12-20 | Centessa Pharmaceuticals plc | 55,000 | $959.1K | $17.44 | 2025-01-21 |
| 2024-12-06 | Centessa Pharmaceuticals plc | 87,496 | $1.62M | $18.46 | 2024-12-20 |
| 2024-11-25 | Centessa Pharmaceuticals plc | 299 | $5.5K | $18.23 | 2024-12-06 |
| 2024-11-22 | Centessa Pharmaceuticals plc | 1,671 | $30.5K | $18.24 | 2024-11-25 |
| 2024-11-21 | Centessa Pharmaceuticals plc | 3,511 | $64.0K | $18.24 | 2024-11-22 |
| 2024-11-20 | Centessa Pharmaceuticals plc | 55,000 | $928.7K | $16.89 | 2024-11-21 |
| 2024-11-13 | Centessa Pharmaceuticals plc | 32,023 | $585.4K | $18.28 | 2024-11-20 |
| 2024-10-23 | Centessa Pharmaceuticals plc | 2,592 | $39.7K | $15.32 | 2024-11-13 |
| 2024-10-22 | Centessa Pharmaceuticals plc | 30,203 | $473.2K | $15.67 | 2024-10-23 |
| 2024-10-21 | Centessa Pharmaceuticals plc | 22,205 | $350.9K | $15.80 | 2024-10-22 |
| 2024-09-20 | Centessa Pharmaceuticals plc | 55,000 | $909.0K | $16.53 | 2024-10-21 |
| 2024-09-10 | Centessa Pharmaceuticals plc | 175,000 | $2.89M | $16.52 | 2024-09-20 |
| 2024-08-23 | Centessa Pharmaceuticals plc | 46,651 | $573.9K | $12.30 | 2024-09-10 |
| 2024-08-22 | Centessa Pharmaceuticals plc | 506 | $6.2K | $12.23 | 2024-08-23 |
| 2024-08-21 | Centessa Pharmaceuticals plc | 3,674 | $45.0K | $12.25 | 2024-08-22 |
| 2024-08-20 | Centessa Pharmaceuticals plc | 4,169 | $51.4K | $12.32 | 2024-08-21 |